VIRBAC CORP
NT 10-K, 2000-03-30
PHARMACEUTICAL PREPARATIONS
Previous: TRACK DATA CORP, 10-K, 2000-03-30
Next: QUALITY DISTRIBUTION INC, 10-K405, 2000-03-30





                            UNITED STATES
                 SECURITIES AND EXCHANGE COMMISSION

                       WASHINGTON, D.C. 20549

                             FORM 12b-25

                      NOTIFICATION OF LATE FILING

(Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q
             [ ] Form N-SAR

         For Period Ended:  December 31, 1999

         [ ]  Transition Report on Form 10-K
         [ ] Transition Report on Form 20-F
         [ ] Transition Report on Form 11-K
         [ ] Transition Report on Form 10-Q
         [ ] Transition Report on Form N-SAR

         For the Transition Period Ended:___________________________

Read  Instruction (on back page) Before  Preparing  Form.  Please Print or Type.
Nothing  in this  form  shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

If the notification  relates to a portion of the filing checked above,  identify
the Item(s) to which the notification relates:

- --------------------------------------------------------------------------------
PART 1 - REGISTRANT INFORMATION

- --------------------------------------------------------------------------------
Full Name of Registrant

Virbac Corporation

- --------------------------------------------------------------------------------
Former Name if Applicable

Agri-Nutrition Group Limited

- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

3200 Meacham Boulevard

- --------------------------------------------------------------------------------
City, State and Zip Code

Fort Worth, TX 76137
- --------------------------------------------------------------------------------


<PAGE>




PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without  unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

[X]               (a)     The reasons described in reasonable detail in Part III
                  of this form could not be eliminated without unreasonable
                  effort or expense;

[X]               (b) The subject annual report,  semi-annual report, transition
                  report on Form 10-K,  Form 20-F,  11-K, Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following the  prescribed  due date; or the subject  quarterly
                  report of transition  report on Form 10-Q, or portion  thereof
                  will be filed on or before the fifth  calendar  day  following
                  the prescribed due date; and

[  ]              (c)      The accountant's statement or other exhibit required
                  by Rule 12b-25(c) has been attached if applicable.

PART III - NARRATIVE

State below in  reasonable  detail the reasons  why the Form 10-K,  11-K,  10-Q,
N-SAR, or the transition  report or portion  thereof,  could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)

In March 1999 the  registrant,  then  known as  Agri-Nutrition  Group,  Limited,
merged with Virbac,  Inc. The registrant's  financial  results have taken longer
than expected to finalize this year because of  integration  issues  relating to
the merger.  As a result of these issues,  the registrant was unable to complete
the report in a timely manner without unreasonable effort or expense.

PART IV - OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
notification.

Henry Haley       817-831-5030

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during the  preceding  12 months  (or for such  shorter)  period  that the
registrant  was  required to file such  reports)  been  filed?  If answer is no,
identify report(s). [X] Yes [ ] No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof? [X]
Yes [ ]No



<PAGE>



If so, attach an explanation of the anticipated  change,  both narratively,  and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

The registrant reported a net loss of $662,832 for its fiscal year ended October
31, 1998. For the nine months ended September 30, 1999, the registrant  reported
net income of  $1,311,000.  The registrant is not able to provide an estimate of
its results for the year ended December 31, 1999 because of the issues discussed
in Part III of this form.

- --------------------------------------------------------------------------------
Virbac Corporation

has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date:    March 29, 2000                     By:  /s/ Henry Haley

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by other  duly  authorized  representative.  The name  and  title of the  person
signing  the form  shall  be typed or  printed  beneath  the  signature.  If the
statement is signed on behalf of the registrant by an authorized  representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

                                    ATTENTION

Intentional  misstatements  or omissions  of fact  constitute  Federal  Criminal
Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1. This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules
and regulations under the Securities Exchange Act of 1934.

2. One signed  original and four  conformed  copies of this form and  amendments
thereto must be completed and filed with the Securities and Exchange Commission,
Washington,  D.C.  20549,  in accordance  with Rule 0-3 of the General Rules and
Regulations  under the Act. The information  contained in or filed with the form
will be made a matter of public record in the Commission files.

3. A manually  signed copy of this form and  amendments  thereto  shall be filed
with each national  securities  exchange on which any class of securities of the
registrant is registered.

4. Amendments to the  notification  must also be filed on form 12b-25,  but need
not restate  information  that has been correctly  furnished.  The form shall be
clearly identified as an amended notification.

5. Electronic Filers. This form shall not be used by electronic filers unable to
timely file a report  solely due to  electronic  difficulties.  Filers unable to
submit a report  within  the  time  period  prescribed  due to  difficulties  in
electronic  filing  should comply with either Rule 201 or Rule 202 of Regulation
S-T or  apply  for an  adjustment  in  filing  date  pursuant  to Rule  13(b) of
Regulation S-T.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission